» Articles » PMID: 15109617

Urotensin II: the Old Kid in Town

Overview
Specialty Endocrinology
Date 2004 Apr 28
PMID 15109617
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Urotensin II (U-II) is a vasoactive hormone that acts through a recently described seven transmembrane-spanning G-protein-coupled receptor called GPR14. Although touted as the most potent vasoconstrictor peptide yet identified, the responses elicited by U-II are species-, tissue- and endothelium-dependent. Available data question the contribution of U-II to resting cardiovascular homeostasis in humans; instead they point to a role for this hormone in disease (heart failure and cardiac cell growth, renal function, diabetes, and mitogenesis in vascular and tumour cells). Key features of these diseases are increased expression and activity of U-II receptors. In this review, we focus on recent evidence that supports a role of U-II and its receptor in cardiovascular disease.

Citing Articles

Signalling pathways involved in urotensin II induced ventricular myocyte hypertrophy.

Al Ali H, Rodrigo G, Lambert D PLoS One. 2025; 20(1):e0313119.

PMID: 39820183 PMC: 11737703. DOI: 10.1371/journal.pone.0313119.


Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice.

Chen X, Yin L, Jia W, Wang N, Xu C, Hou B Front Endocrinol (Lausanne). 2019; 10:453.

PMID: 31379736 PMC: 6660256. DOI: 10.3389/fendo.2019.00453.


Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels.

Oral E, Halici Z, Cinar I, Ozcan E, Kutlu Z Clin Psychopharmacol Neurosci. 2019; 17(2):211-221.

PMID: 30905121 PMC: 6478082. DOI: 10.9758/cpn.2019.17.2.211.


Urotensin receptors as a new target for CLP induced septic lung injury in mice.

Cadirci E, Ugan R, Dincer B, Gundogdu B, Cinar I, Akpinar E Naunyn Schmiedebergs Arch Pharmacol. 2018; 392(2):135-145.

PMID: 30353214 DOI: 10.1007/s00210-018-1571-8.


Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.

Wang Y, Tian W, Xiu C, Yan M, Wang S, Mei Y Clin Rheumatol. 2018; 38(1):29-35.

PMID: 29362961 DOI: 10.1007/s10067-018-3978-5.